FDA Warning Wire: Stem Cell Study, Bad OTC Promos

By Jeff Overley (March 28, 2017, 7:37 PM EDT) -- A prominent physician at Northwestern University failed to promptly report deaths in a stem cell study, a seller of popular over-the-counter treatments made dubious health claims, and a manufacturer of contact lens solution sold leaking and unreliable products, according to U.S. Food and Drug Administration warning letters published Tuesday.

Doc's Clinical Trial Oversight Assailed

A 5,000-word warning letter to Northwestern University physician Richard K. Burt — chief of immunotherapy in the school's Department of Medicine — was sharply critical of how Burt has supervised a long-running clinical trial involving stem cell transplants. 

Much of the criticism focused on alleged failures to...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!